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Comparison of 4 Direct Coombs’ Test Methods with Polyclonal Antiglobulins in Anemic and 
Non-anemic Dogs for In-Clinic or Laboratory Use 
 
 
Background:  Difficulties with the direct antiglobulin test (DAT) and its apparent lack of sensitivity 
and specificity for canine immune-mediated hemolytic anemia (IMHA) has raised skepticism 
regarding its diagnostic value.  
Objective:  Prospective study comparing different DAT and other methods. 
Animals:  Anticoagulated blood samples from 59 non-anemic and 46 anemic dogs (+/- IMHA) from 
a research colony and veterinary clinics. 
Methods: Immunochromatographic strip, gel microcolumn and capillary techniques were compared 
to standard microtiter DAT using 2 polyvalent antiglobulins. Spherocytosis, autoagglutination, 
osmotic fragility and clinical data were assessed. 
Results: Blood samples from all 59 non-anemic dogs were DAT-. Among 46 anemic dogs, 33 were 
suspected of IMHA, but only 20 were to various degrees DAT+. Spherocytosis and autoagglutination 
(that did not persist after washing) were noted in 15 and 16 DAT+ dogs, respectively. The other 26 
anemic dogs, including 21 previously transfused dogs and 4 with autoagglutination, tested DAT- by 
different methods. Osmotic fragility was increased in 70% (19/27) of anemic and all 15 DAT+ dogs 
tested.  
Conclusions and Clinical Importance: The novel strip and capillary DAT appear to be promising 
adjunct in-clinic tools. Despite prior immunosuppressive treatment and presence of autoagglutination, 
DAT was positive in anemic dogs with IMHA; transfusion did not cause any false DAT+. Our results 
support DAT as a cornerstone in IMHA diagnosis.  
 
Short Title: Comparison of Various Canine Coombs’ Tests. 
 
Key words: Immune-mediated hemolytic anemia; autoantibodies; osmotic fragility; direct 
antiglobulin test. 
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Zusammenfassung 
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Vergleich von 4 Direkten Coombs-Test-Methoden mit Polyklonalen Antiglobulinen bei 
anämischen und nicht-anämischen Hunden für den Praxis- oder Laborgebrauch 
 
 
Hintergrund: Der direkte Antiglobulin-Test (DAT) für die Diagnose der immunbedingten 
hämolytischen Anämie (IHA) beim Hund wird wegen vermuteter geringer Sensitivität und Spezifität 
selten klinisch angewandt. 
Ziel: Prospektive Studie, die verschiedener DAT Methoden vergleicht. 
Tiere: Blutproben von 59 nicht-anämischen, 46 anämischen Hunden (+/- IHA) von Kliniken und 
einer Hundekolonie. 
Methoden: Immunchromatographische Streifen-, Gel- und Kapillar-Techniken wurden mit der DAT-
Mikrotiterplatte und 2 polyvalenten Antiglobuline verglichen. Sphärozytose, Autoagglutination, 
osmotische Fragilität und klinische Daten wurden ausgewertet. 
Ergebnisse: Blutproben aller 59 nicht-anämischen Hunde waren DAT-. IMHA wurde bei 33/46 
anämischen Hunde vermutet; jedoch waren nur 20 DAT+ mit der Mikrotiterplatte und anderen DAT 
Methoden. Von den 20 DAT+ Hunden zeigten 15 Sphärozytose, 16 Autoagglutination. Die anderen 
26 anämischen Hunde, darunter 21 zuvor transfundierte Hunde und 4 mit Autoagglutination, hatten 
DAT- Ergebnisse. Alle 15 DAT+ untersuchten Hunde, sowie 70% der anämischen DAT-, wiesen eine 
erhöhte osmotische Fragilität auf. 
Schlussfolgerungen, Klinische Bedeutung: Die neuen Streifen- und kapillare DAT erwiesen sich als 
vielversprechende Methoden für die Klinik. Anämische Hunde mit IHA zeigten trotz Behandlung mit 
Immunsuppressiva und Autoagglutination, DAT+ Ergebnisse. Transfusionen verursachten keine 
falsch+ Resultate. Unsere Studie zeigt die Nützlichkeit des DAT zur IHA-Diagnostik. 
 
Schlüsselwörter: Immunbedingte hämolytische Anämie; Autoantikörper; osmotische Fragilität; 
Direkter Antiglobulintest. 
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Abbreviations 
 
 
AT antiglobulin testing band 
Capillary capillary tube method 
C control lectin band 
DAT direct antiglobulin test 
DEA  dog erythrocyte antigen 
EDTA ethylenediaminetetraacetate 
Gel gel microcolumn method 
Hb  hemoglobin 
Ig (G, M) immunoglobulin (G, M) 
IMHA immune-mediated hemolytic anemia 
Microtiter  microtiter plate method 
min minutes 
n  number 
OF(T) osmotic fragility (test) 
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Introduction 
 
Dr. Robin Coombs first introduced the antiglobulin test, referred to as the Coombs’ test, into 
human clinical practice in 1945.1 This immunohematological technique has proven invaluable, 
specific and sensitive in the detection of erythrocytic auto- and alloantibodies documenting immune-
mediated hemolytic anemia (IMHA), hemolytic transfusion reactions and hemolysis of the newborn.1, 
2 The direct antiglobulin test (DAT) detects immunoglobulin (Ig) and/or complement bound to the 
surface of red blood cells (RBCs).3, 4 Since the initial conventional tube Coombs’ test, several 
additional methods using microtiter plates, capillary tubes, gel microcolumns, and flow cytometry 
have been developed. Also, a variety of reagents from polyvalent to specific Ig and complement 
reagents, under various incubation conditions have been applied.5 
The DAT has also been used with species-specific reagents in veterinary medicine, mainly in the 
diagnosis of IMHA in dogs.6-10 However, difficulties in performing the DAT, subjective result 
interpretation, and its apparent lack of sensitivity and specificity for IMHA have overshadowed its 
clinical diagnostic usefulness.8, 10, 11 Anecdotally, clinicians speak of “Coombs’-negative IMHA” 
dogs;7, 12, 13 and some skip the Coombs’ test altogether as DAT+ results are rarely received from 
clinical pathology laboratories. Furthermore, the autoagglutination observed in 
ethylenediaminetetraacetate (EDTA) tubes or on microscopic slides (with or without adding a drop of 
saline) is commonly considered sufficient for the diagnosis for IMHA and is also thought to interfere 
with DAT performance.9, 14 Moreover, there is a sense that immunosuppressive therapy will 
immediately convert DAT+ dogs to “false-negative DAT” results and that even one transfusion will 
cause a “false-positive DAT” result.14-17 Finally, the erythrocytic osmotic fragility (OF) test (OFT) at 
specific saline concentrations (5, 50 and 90%) is by some considered a diagnostic test for IMHA.7, 12 
In light of the perceived uncertainties of the value of the Coombs’ test and the introduction of 
newer techniques, a prospective study aimed at comparing various laboratory and in-clinic 
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immunohematological DAT methods to detect warm allo- and autoantibodies in anemic and non-
anemic dogs prior and/or after treatment and/or transfusion was undertaken. The presence of 
autoagglutination, spherocytosis and increased OF was also assessed, and clinicopathological and 
therapeutic information of dogs was evaluated where available. 
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Materials and Methods 
 
Animals and Samples 
 
From April to October 2012 a free-of-charge extended laboratory assessment of anemic dogs, in 
particular those suspected of having IMHA, was offered as part of their diagnostic evaluation by 
notifying ACVIM diplomates and other referral clinicians in the USA via email. Small (1-3 ml) 
EDTA-anticoagulated blood samples from 24 anemic dogs, freshly collected, chilled and shipped on 
ice, were received by overnight mail along with similarly prepared samples from 17 healthy non-
anemic dogs, to control for shipping artifacts. Leftover EDTA blood samples from 22 anemic and 11 
non-anemic dogs submitted to the Clinical Pathology Laboratory at the Veterinary Hospital of the 
University of Pennsylvania (VHUP) were also assessed, as well as samples from 31 non-anemic dogs 
in the research colony at the University of Pennsylvania. All samples were stored at 4°C for less than 
48 hours until processing. Lipemic samples that could compromise OF testing were not used. 
 To investigate effects of sample storage, 34 blood samples (11 anemic DAT+ samples and 23 
non-anemic DAT- colony dogs) were repeatedly tested by DAT methods on subsequent days after 
blood collection. Additionally, 9 DAT+ and 8 DAT- anemic dogs were followed up by repeat testing 
during monitoring of disease progression and treatment response. Signalment (Supplement), routine 
clinicopathologic and therapeutic information from each dog were also reviewed. Distinction between 
primary and secondary IMHA was not made. The authors, who established methods and routinely 
performed these immunohematological techniques, conducted all testing. The Institutional Animal 
Care and Use Committee at the University of Pennsylvania approved these studies. 
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Laboratory methods 
 
Routine Hematology Studies –If not already included with the shipped, received samples, blood 
smears were prepared and stained with Wright Giemsa a  on arrival for manual microscopic 
examination. Spherocytosis was recorded, if there were at least 20 spherocytes per 100X microscopic 
field (all others had <2 per 100X field).11  
Autoagglutination was assessed first by visual examination of the EDTA tube and by microscopy 
of the blood smear; if positive, saline agglutination of EDTA blood was performed by adding a drop 
of physiological saline (0.9% NaCl) to a drop of blood on a slide.11, 14 Finally, after washing the RBC 
pellet 3 times by adding 4-6 parts phosphate buffered saline (PBSb) to 1 part of packed RBCs, mixing, 
centrifuging for 5 min at 1000 gc and each time discarding the supernatant to remove any remaining 
plasma proteins; agglutination was evaluated macro- and microscopically. The washed packed RBC 
samples that retained aggregates were said to exhibit persistent or true agglutination.9, 10, 18 The PCV 
of EDTA blood samples was determined by standard microcentrifugation; whole blood and plasma 
hemoglobin (Hb) concentrations were measured by HemoCued; DEA 1.1 blood type was determined 
by the immunochromatographic strip method.19 
To technically validate various antiglobulin tests for this study, conditions for positive and 
negative reactions were established (Supplement). For this prospective study 3 DAT methods based 
on RBC agglutination were compared: microtitere plate (Microtiter) using canine antiglobulin reagent 
Mf (raised in rabbit) and reagent Vg (goat), capillaryh tube (Capillary, Fig. 1A) and geli microcolumn 
(Gel) technique. Additionally, all samples were tested using a novel immunochromatographic stripj 
method (Strip, Fig. 1B), where antibody coated RBCs migrate and bind to a band impregnated with 
antiglobulin.  
For the various DAT methods, washed RBC suspensions were stored at 4°C for <2 hours, 
microscopically examined for autoagglutination, and tested according the manufacturers’ instructions 
and as published and briefly described in Supplement. A DAT+ result indicates the presence of 
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erythrocytic autoantibodies and was used as a criterion for immune-related erythrocyte destruction. A 
standard OFT was performed, as described in Supplement. 
 
Assessment of various DAT techniques 
 
The various DAT methods applied in the subsequent studies were optimized such that (1) RBCs 
from DEA 1.1+, but not DEA 1.1- dogs strongly reacted with polyclonal anti-DEA 1.1 alloantibodies, 
(2) RBCs from DEA 4+ RBCs reacted positively with anti-DEA 4 alloantibodies, and (3) RBCs from 
4 known DAT+ dogs with IMHA but not those from 18 healthy control dogs gave DAT+ results with 
both reagent M and V (Supplement).  
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Statistical Analysis  
 
Data was entered into a spread sheetk and grouped into non-anemic and anemic dogs and based 
upon diagnostics according to spherocytosis, agglutination, and DAT results. Data was examined for 
normal distribution. To determine differences between results obtained with various methods, 2x2 
tables were used. Kappa (k), the percentage agreement between results of Microtiter-M and other 
methods beyond chance, was calculated using a clinical research calculatorl. Based upon OF curves, 
mean values of hemolysis at OF 5%, 50% and 90% were statistically compared with an independent-
sample t-test m . Probability values p<0.05 were considered statistically significant. Descriptive 
statistics for the relationships are expressed as mean±SD (PCV, Hb, age, OF).  
 
Comparison of Various Canine Coombs’ Tests 
13 
Results 
 
Direct Coombs’ test results in non-anemic dogs 
 
Of 105 dogs studied, blood samples from the 59 non-anemic dogs gave uniformly DAT- results 
by all methods used. None of these dogs showed any evidence of anemia, hemolysis, agglutination or 
spherocytosis. (Table 1)  
 
Direct Coombs’ test results in anemic dogs 
 
Among the 46 anemic (PCV ≤37%) dogs, 20 were DAT+ and 26 DAT- by Microtiter-M (titer >8, 
used as reference method). Lowest and highest positive titers observed were 8 and 2048, respectively. 
The failure to agglutinate at low antiserum dilutions caused by a relative excess of antiglobulin in 
relation to antigen, called the prozone effect, was observed in 4 DAT+ dogs. In 2 dogs, the prozone 
effect was observed up to a titer of 16 with agglutination seen beyond till a titer of 64 and 128 and in 
the 2 other dogs the prozone effect was seen till a titer of 64 with final agglutination titer seen at 512 
and 1024, respectively.  
The degree of DAT positivity (Fig. 2), where gradable, varied but correlated well between 
techniques: Reagent M gave uniformly equal to twice as strong titers compared to reagent V by 
Microtiter. (Fig. 2A) All DAT methods used in this comparative study gave similar results when 
performed at 37°C, 22°C or 4°C, but agglutination with Microtiter was more readily interpretable 
after incubation at 37°C and 4°C. Among 20 DAT+ dogs determined by Microtiter-M, the Strip 
revealed weakly positive (1+ to 2+) bands in 12 dogs, strongly positive bands (3+ to 4+) in 7 dogs and 
missed 1 dog as positive. (Fig. 2B) In contrast, the Capillary and Gel (Fig. 2C) results of the DAT+ 
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dogs gave uniformly strong agglutination reactions, which were easy to read and interpret. Also in the 
Capillary assay reagent M subjectively gave more and larger beads (agglutination) than reagent V and 
thus concordant DAT+ results with the following exception: A 4-year-old female spayed 
Newfoundland with anemia and spherocytosis was only transiently (3 days) weakly to moderately 
positive by the Microtiter-M (titer 8 and 64) and Capillary test, while all other DAT results were 
persistently negative. The dog recovered from anemia within 5 days.  
The DAT- samples, as determined by Microtiter-M, from 26 anemic dogs were also DAT- by all 
other methods, with the following 2 exceptions: A 13-year-old castrated male Labrador retriever had 
an isolated positive Capillary result and was later found to have intestinal leiomyosarcoma but no 
hemolysis. A 7-year-old spayed female Bernese mountain dog had a weakly positive Strip (1+) result 
with all other DAT results negative and was later diagnosed with malignant histiocytosis and 
secondary erythrophagocytosis. 
Most notably, results obtained using various DAT methods results were highly concordant: 19 out 
of 20 DAT+ dogs by Microtiter-M also had DAT+ results with every other method. Agreements 
between Microtiter-M and V, Gel, Strip or Capillary had kappa values of >0.94 and a 95% confidence 
interval of 0.85-1, which represent strong agreements between various DAT results. (Table 2 in 
Supplement) 
 
Association between clinically suspected IMHA diagnosis, spherocytosis and autoagglutination with 
DAT results 
 
The PCV and plasma Hb values of DAT+ dogs were significantly lower and insignificantly 
higher than those of DAT- dogs, respectively, reflecting intravascular hemolytic anemia in some cases. 
(Table 1)  
Among 33 anemic dogs considered by clinicians to likely have IMHA (based on clinical 
impression, autogglutination on slide and review of blood smear, but rarely performing a Coombs’ 
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test), 13 dogs (39%) were DAT- by Microtiter-M and also by other methods (see 2 singular 
exceptions above).  Further clinical follow-up, when available, revealed that these DAT- dogs had 
other reasons for anemia, including neoplasia (7), pancreatitis (1), iron deficiency anemia (1), 
pyometra with surgical complications (1), and cholelithiasis with surgical complications (1). None of 
these dogs had any evidence of spherocytosis or hemolysis, but 3 of these dogs showed agglutination 
that did not persist after washing. None of these had any DAT+ results from any outside laboratories. 
In addition, 13 of 46 anemic dogs that were not suspected of having IMHA and were DAT- had 
neoplasia (lymphoma [3], liver mass [2], spindle cell sarcoma [1]), surgical complications (4; lung 
torsion, cruciate ligament, liver mass surgery, trauma), chronic osteoarthritis (1), hemophagocytic 
syndrome (1), and pure red cell aplasia (1).  
None of the 26 DAT- dogs had spherocytosis, and 4 dogs exhibited agglutination that was not 
persistent after washing. 
All 15 anemic dogs with marked spherocytosis were DAT+ by Microtiter-M and all but one also 
DAT+ by all other DAT methods; 13 also showed autoagglutination that was not persistent. 
Autoagglutination was noted in 20 anemic dogs, but was not persistent and thus DAT could be 
performed and interpreted: 16 agglutinating samples were DAT+ and 4 were DAT- by all methods. 
None of the latter had any evidence of IMHA, and were later diagnosed with pure red cell aplasia, 
malignant histiocytosis, intestinal leiomyosarcoma and multisystemic organ failure, respectively.  
 
Effects of Transfusion on DAT Results 
 
Among 46 anemic dogs, 37 dogs received DEA 1.1-matched RBC transfusions: 11 anemic dogs 
not suspected of having IMHA were transfused 1 to 21 days prior to Coombs’ test performance; all 
were DAT-. Another 10 dogs clinically suspected of having IMHA, transfused 1 day to 5 years before 
testing, also had DAT- results; they had neither spherocytosis nor hemolysis. Among 20 DAT+ dogs, 
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16 were transfused: 12 were tested before receiving a transfusion and 4 had been transfused just 1 to 2 
days before testing.  
 
Effects of Immunosuppressive Therapy on DAT Results 
 
Immunosuppressive therapy (glucocorticosteroids and other immunosuppressives) was given to 
22 anemic dogs: 12 of 16 DAT+ and 10 DAT- anemic dogs were pretreated with immunosuppressive 
drugs for 4 days to 2 years (details of dates, drugs, and dosage were not available) before performing 
DAT; whereas 4 dogs were only immunosuppressed after obtaining DAT+ results.  
 
Follow up DAT Results to Monitor IMHA 
 
Retesting of 8 DAT- and 9 DAT+ anemic dogs for days to weeks revealed that all DAT- dogs 
persistently remained negative in all DAT analyses. In contrast all 9 DAT+ dogs remained positive for 
at least 3 days, and 6 were DAT+ for >10 days. Two dogs followed beyond 10 days became DAT- by 
26 and 96 days (Table 3), respectively, and remained DAT-. Concomitantly, the anemia resolved and 
other hematological parameters normalized.  Additionally, 34 DAT- non-anemic research dogs 
assessed multiple times (6-96 days; average time between tests 40 days) remained DAT-. Finally, 
samples stored at 4°C from 11 DAT+ dogs tested were consistently positive by all DAT methods for 7 
days, while all 23 DAT- samples tested remained negative over the same time span.  
 
Erythrocytic OFT Results 
 
In contrast to 28 non-anemic dogs, which all had normal OF curves, erythrocytic fragility was 
increased in 70% of 27 anemic dogs tested, including 15/15 DAT+ and 4/12 DAT- dogs (Table 4). 
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Two of the 4 DAT- dogs with increased OF had lymphoma and in the other 2 the diagnosis remained 
unknown. All 12 spherocytic DAT+ dogs tested had increased OF with a right shift of the sigmoid OF 
curve toward physiological saline concentrations. (Fig. 3A) Values of OF 5% and 50% from DAT+ 
dogs showed a significantly increased degree of lysis compared to healthy non-anemic dogs (Table 4). 
In the 5 DAT+ dogs that also had spherocytosis and agglutination, the OF curve was not only shifted 
to the right but also flattened. This specific pattern with slightly decreased lysis around OF 90% and 
increased lysis at near physiological saline concentration (OF 5%) was not observed in any DAT- 
anemic dogs. (Fig. 3B) 
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Discussion 
 
Accelerated destruction of RBCs induced by autoantibodies (and complement) is the hallmark of 
IMHA.10, 20, 21 While autoagglutination and spherocytosis may suggest an immune process, only the 
DAT can specifically document the presence of autoantibodies on RBCs.2-5, 8 Because of concerns 
regarding the methodologies, validity, sensitivity, and specificity of the DAT in canine medicine,6, 8, 9, 
11 we compared various DAT techniques, including novel in-clinic tests, using polyclonal canine 
antiglobulins and other parameters in a select group of anemic and non-anemic dogs prospectively. 
After establishing and optimizing each technique in our laboratory and confirming that our assays 
specifically detected erythrocyte bound allo- and autoantibodies, DAT+ results were observed in 20 of 
46 anemic dogs, but not in any of the 59 non-anemic dogs. Moreover, observed DAT results 
correlated between various methods used as well as with the patients’ manifestations and other 
parameters (e.g. spherocytosis) suggestive of IMHA, thereby reestablishing the DAT’s clinical 
usefulness in the diagnosis of IMHA. 
Although, there is no DAT gold standard in human and veterinary immunohematology,8, 16, 21 the 
tube assay6 was the standard laboratory DAT technique in the past. However, this is a tedious 
procedure prone to varied test execution and interpretation of test results.11 For the studies presented 
here, we applied a commonly used, but often poorly described, 96-well microtiter plate technique 
(with reagent M) as a reference method.2, 11, 13  
In the present study, canine specific polyclonal antiglobulin M (rabbit) was used as reference 
reagent and results were nearly identical with reagent V (goat) thereby corroborating their specificity. 
Specific anti-IgG, IgM, and complement reagents were not used to further characterize results of 
DAT+ samples in this study.  
While warm autoantibodies generally cause hemolysis, the best temperature at which to perform 
the DAT is debatable.8, 11 The similarity in DAT+ results might be partly due to sequential 
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performance from 22°C to 37°C and 4°C and extended length of incubation at 4°C. Others22, 23 also 
observed that DAT sensitivity could improve after a period of cold incubation: optimal performance 
was found at both 4°C and 37°C, with both polyvalent and monovalent antiglobulins. Thus, 
incubation at room temperature may be sufficient to screen for DAT+ anemic dogs, which could 
simplify and quicken the procedure. 
Extended titration of antiglobulin to 2048 not only allowed determination of the strength of the 
agglutination reaction, but also overcame the previously described interfering prozone effect at lower 
titers.8, 11, 16, 23 However, other DAT methods used here were set up with 1 fixed antiglobulin 
concentration, which, interestingly, gave very similar results and did not seem to affect sensitivity and 
specificity of DAT results. In a clinical setting, DAT methods with a single reagent concentration 
could greatly simplify the process and interpretation of results. 
The gel microcolumn method uses a standardized procedure to specifically detect antibodies, 
offers a grading scale for objective interpretation, and has been widely used in immunohematology in 
humans2, 24 and more recently in veterinary medicine.8 This technique became the standard method for 
canine and feline blood typing.19, 25 Initial experiences from our laboratoryn and others16 with the 
reagent M containing gel columns used as DAT were very encouraging. Similarly, in the study 
reported here, the DAT results with the Gel correlated well with the Microtiter-M and all other 
techniques, but unfortunately the Gel is no longer commercially available for dogs.  
The capillary microtube test, introduced in the 1950’s26 to detect antiglobulins, is still being used 
in human blood banking as a screening test for auto- and alloantibodies.5 To the authors’ knowledge, 
the study presented here is its first application in veterinary medicine. The Capillary was quick and 
easy to perform, requiring no special equipment and only small quantities of reagent M (or V), and 
results were readily interpretable. Moreover, the obtained Capillary results corresponded very well 
with all other methods used. Thus, the Capillary method may be well suited to become the first in-
clinic method to detect the presence of autoantibodies on RBCs in dogs. 
The Strip is an innovative and entirely new approach to immunohematology, which recently has 
already proven invaluable for canine and feline blood typing19 and is being developed for in-clinic or 
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laboratory DAT by the same manufacturer. It utilizes an immunochromatographic strip with 
impregnated reagent M to bind antiglobulin-coated RBCs and thus is not an agglutination-based test. 
In our experience the Strip was easy to perform, but the resulting band strengths were frequently weak, 
which could make interpretation a little difficult. Our DAT+ Strip results, which included the weak 
bands, correlated well with those of other DAT methods and thus can readily be used as an in-clinic 
screening test.  
While various DAT methods results correlated extremely well among the techniques used, DAT+ 
results also seemed to be restricted to those dogs with evidence of hemolysis and/or suspected of 
having IMHA. Of the 46 anemic dogs, 33 were suspected by clinicians to have clinically IMHA and 
20 were found to be DAT+. Further evaluation of the 13 DAT- anemic dogs did not reveal any 
specific features of IMHA, and 11 of these DAT- dogs had either evidence of another underlying 
disorder and/or mechanism of anemia. Thus, the DAT methods used appear to be sensitive and 
specific to detect dogs with IMHA. The high specificity for all DAT techniques described in this 
study was similar to that reported in a recent study comparing 2 methods.11 Most methods, including 
all used here detecting antiglobulins against RBCs, require previous washing of RBCs, which is a 
critical technical step, because plasma antibodies not specifically bound to RBCs in an assay, can 
compete and negatively impact results. In humans with IMHA autoantibodies are not typically 
removed by repeat washing,27 they are tightly bound to RBCs and special methods have to be used to 
elute off the autoantibodies from the red cell surface.28 However, there is no specific data on 
autoantibody binding in dogs and any low affinity antibodies being missed by the DAT and causing 
hemolysis. In the small study presented here there were no cases of suspected IMHA and DAT- 
results, where there was any other evidence of an immune process causing hemolytic anemia. 
Similarly concerns have been raised that the DAT had to be performed immediately following 
blood collection. However, in this study repeat testing of stored chilled EDTA samples from11 DAT+ 
dogs gave identical results for one week. Hence, samples prior to emergency or acute treatment can be 
stored at 4°C and shipped later to a laboratory when deemed necessary to request a DAT without 
causing false-negative DAT results.  
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Autoagglutination is frequently considered diagnostic for canine IMHA. In retrospective studies it 
has been seen in 42-87% of IMHA cases, and is commonly used as a reason to not perform a DAT.13, 
29, 30 However, the degree of agglutination varies, may be unspecific, and may not interfere with 
Coombs’ testing as the agglutination is frequently not persistent. In this study 20 anemic dogs 
exhibited autoagglutination in tube or on slide, but in all cases agglutination did not persist after 
washing, which permitted the performance of the DAT. Moreover, the DAT was positive in 80% 
(16/20) of agglutinating dogs; the other 4 DAT- dogs seemed to have no evidence of hemolysis and 
had other conditions. Thus, while agglutination may suggest a diagnosis of IMHA, it should be 
followed up with washing and performance of a DAT to document autoantibody-mediated 
autoagglutination when possible. Agglutination without washing is shown here to be not diagnostic on 
its own, with 4 agglutinating dogs having DAT- results; they also had no evidence of spherocytosis 
and hemolysis and were having other diseases. Beside the data in this prospective study, this has also 
been observed in many other cases.10, 18  
Spherocytosis is considered a hallmark feature of IMHA in dogs.12 In this study severe 
spherocytosis was seen in 75% of DAT+ and no DAT- dogs. Other studies also observed that 67-94% 
of dogs affected by IMHA had spherocytosis.9, 13, 18, 29, 30 However, spherocytes may also be seen with 
other acquired hemolytic conditions (only few spherocytes)12 and with hereditary spherocytosis.31 
Moreover, in clinical practice blood smears should be carefully reviewed for spherocytes in the 
appropriate fields on a slide and preferably analyzed by a veterinary diagnostic laboratory and 
experienced person or clinical pathologist to avoid false interpretations.32 Thus, while marked 
spherocytosis is highly suggestive of IMHA, additional cases are discovered by performing a DAT, 
which can also confirm the immune mechanism of partial intravascular lysis and/or phagocytosis 
leading to spherocytosis.30  
The sensitivity of DAT for IMHA in dogs is widely debated ranging from 50% to 89%.6, 8, 11, 12, 18, 
22, 29, 30 False-negative DAT results have been attributed to technical difficulties with the assay, such as 
inappropriate or inadequate strength of antisera, exclusive cold agglutinins, failing to adequately wash 
RBCs, prozone effect, low affinity or quantities of autoantibodies on RBCs or presence of drug-
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induced autoantibodies.6, 11, 14 However, the specific cause has generally not been determined.8, 14 
Optimizing techniques in each laboratory and using standard methods and positive controls could help 
prevent false-negative DAT results. Based upon analysis of available clinical information in the study 
reported here, the DAT detected likely all dogs with IMHA.  Thus, DAT- dogs should be examined 
for other causes of anemia. For instance nearly all anemic dogs, found in the authors’ laboratory to 
suffer from hereditary erythrocyte defects, had been assumed to be having IMHA and were previously 
treated for weeks to years for IMHA and the DAT was either negative or never done (data not shown). 
The efforts and costs of performing a DAT to confirm a diagnosis of IMHA seem negligible, when 
considering the costs for other tests, unnecessary treatment and potential side effects of 
immunosuppressive agents in an anemic dog with other diseases. 
Many clinicians believe that administration of immunosuppressive therapy will cause 
immediately false DAT- results,9, 14, 16 although the dose and duration of immunosuppressive 
treatment needed to affect DAT results are poorly documented.11, 14, 17, 20 This potential drug 
interference has been used as another reason for not performing a DAT. However, in this study 
anemic dogs treated with immunosuppression had DAT+ results that remained positive for days to 
weeks, as previously observed by others.12, 17 Thus, contrary to common belief, Coombs’ testing is 
recommended in anemic dogs even when already treated. Of course once an animal responds to 
treatment and goes into remission (normalizes its PCV and has no more evidence of hemolysis), the 
DAT becomes negative as shown here and elsewhere.11, 17  
Various reports suggested that previous blood transfusions, especially 1-21 days before 
performing a DAT, could cause false-positive results.14, 15 However, no effect of transfusion on DAT 
could be documented here in this and other studies.11, 30 This is clinically important, as likely over half 
of IMHA patients require transfusion during acute management.13, 29  
The OFT has been developed as a screening test to detect RBC membrane defects such as 
hereditary spectrin deficiency and stomatocytosis.31, 33 We also described cats with massively 
increased OF presumably due to a membrane defect.34 In light of in the past-perceived difficulties 
with the DAT, increased erythrocytic OF has been proposed as a diagnostic test result for canine 
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IMHA. It was assumed that spherocytes or antibody-coated erythrocytes could not withstand lower 
saline concentrations as well as normal canine RBCs.12 An increased OF was reported in 85% of dogs 
previously diagnosed with IMHA.6 In the prospective study reported here, all DAT+ tested but also 
some DAT- dogs had increased erythrocytic OF. Thus together with previously reported hereditary 
and likely other acquired RBC membrane defects resulting in increased RBC fragility, the OFT is not 
specific for IMHA.  Moreover, several DAT+ dogs with autoagglutination and spherocytosis had not 
only a right-shifted but flattened sigmoid curve: resistant younger RBC population and fragile 
microspherocytes may explain this unique pattern. However, this complete OFT is fairly cumbersome 
to perform and may be difficult to interpret particularly if baseline hemolysis exists, thus we cannot 
recommend this test for the diagnosis of IMHA.  
This study included only a small number of animals and cases tested under special laboratory 
conditions, blood smears were analyzed by clinical pathologists and the person performing DAT was 
not blinded to other clinical results or other test outcomes. Therefore, further larger studies are needed, 
with specific protocols, to confirm these promising findings. 
In conclusion, this study shows an excellent correlation between various DAT techniques with the 
reference Microtiter-M method, clinical signs of hemolytic anemia, spherocytosis and true 
agglutination. As in human medicine, the DAT remains the most sensitive and specific tool to 
specifically diagnose canine IMHA and seems resilient to storage, immunosuppression and 
transfusion artifacts.10, 11, 35 The Capillary and Strip methods are novel and promising simple in-clinic 
screening tools for IMHA in dogs. 
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Supplementary Material 
 
Methods 
 
Signalment: Among the 59 non-anemic dogs there were 37 purebred (<3 per breed) and 22 
mixed breed dogs, 33 were spayed females and 26 were males; 36 dogs were DEA 1.1+. Of the 20 
DAT+ dogs, there were 4 American Cocker Spaniels, 3 Beagles, 3 mix breed dogs, 2 Poodles, 2 
Pembroke Welsh Corgis, and one from the following breeds: Old English sheepdog, Jack Russell 
terrier, Bull terrier, Miniature schnauzer, Newfoundland, and Basenji. There were 12 females (9 were 
spayed) and 8 castrated males. This group included 12 DEA 1.1+ and 8 DEA 1.1- dogs. The median 
age at the time of first diagnosis of IMHA was 7 years (range, 1-17 years). Of the 26 anemic DAT- 
animals, there were 17 purebred (<3 per breed) and 9 mixed breed dogs, 17 were females (13 were 
spayed) and 9 were castrated males; 16 were DEA 1.1+. 
Validation of DAT Techniques: A 5% suspension of 25 µl washed RBCs from each DEA 1.1+ 
and DEA 1.1- (all were also DEA 4+) non-anemic dogs were incubated at 37°C for 30 min, in 
subagglutinating concentrations with 25 µl polyclonal anti-DEA 1.1 or anti-DEA 4 alloantibodies 
(American Blood Resources International), respectively. Thereafter the mixture was washed 3 times 
with PBSo before preparing 5% RBC suspensions for the DAT. Additionally, 4 samples from known 
DAT+ dogs (not included in study population) were available to optimize the assays prior to the start 
of this prospective study and to confirm that methods used were detecting bound antibodies on RBCs. 
Microtiter-M and -V Test – The DAT in the microtiter plate is similar to the original tube 
agglutination method, but adapted to a 96-well-plate.1, 6, 8, 9, 11, 16, 23 Two different commercially 
available polyclonal canine antiglobulin sera recognizing IgG, IgM and complement were used: 
Reagent Mp was raised in the rabbit and reagent Vq in the goat and the assays were essentially 
performed according to manufacturers’ guidelines and previous studies6, 16: Briefly, series of 25 µl 
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doubling dilutions of antiglobulin (reagent M and V were used in parallel on the same microtiter 
plate) from 1:2 to 1:2048 were prepared. To each well 25 µl of a 5% RBC suspension were added and 
thoroughly mixed by use of a semi-automatic micropipette r . For each tested sample, one well 
containing RBCs in PBS (without serum) was used as a negative control to detect autoagglutination. 
Additionally, a non-anemic control sample was run in parallel with any patient sample as another 
negative control. Microtiter plates were gently agitated and then incubated initially at room 
temperature (~22°C) for 30 min. After recording the agglutination reaction of the lowest and highest 
titers for each sample row, the agglutination was completely dispersed and placed in the incubator at 
37°C for another 30 min. After recording those results, suspensions in plates were again swirled 
gently, covered and placed in the refrigerator at 4°C overnight (12-15 hours). A pellet at the bottom of 
the well indicates a DAT- result, whereas agglutination, visually revealed by a net of RBCs 
preventing settling at the bottom, signifies a positive test result. Titer results are expressed as the 
reciprocal of the highest dilution of antiserum at which autoagglutination is still observed.16, 36 
Gel Test – The gel in the gel matrix in microcolumn contains reagent M (DiaMed)s. Diluent and 
gel cards were stored at 2-8°C and allowed to warm to room temperature before use. This Gel test was 
performed according to manufacturer’s instructions, using a 1% washed RBC suspension (10µl RBCs 
in 1 ml low ionic strength saline solution and a specific centrifuge t and following guidelines of 
previous studiesu.16, 24 Methodologies as well as result interpretation by a grading scale from 0 to 4+ 
were applied as for blood typing. 19, 25 A grade of ≥2+ agglutination was considered a DAT+ result. 
Capillary Test – More than a century ago a capillary tube test was described 37 for the detection 
of RBC antigens, such as the Rhesus factor in human medicine, using specific antiglobulins. 26 and we 
adapted this technique for a DAT. A 0.45 mm wide and 7 cm long capillary tubev (wider than a 
typical microhematocrit capillary is dipped into either reagent M or V until one third of the length is 
filled by capillary force. The antiglobulin-filled end of the capillary is dipped into a 30% washed RBC 
suspension and an amount roughly equal to the serum is drawn into the capillary. Care must be taken 
to avoid ‘air-locks’ between reagent and RBC suspension. The capillary is then inverted, the lower 
end is sealed and left in clay with an inclining angle of 60°, in order for the RBCs to pass through the 
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serum for 10 min.  5, 38-40 Positive Capillary test results show beads or clumps of agglutinated cells 
along the length of the capillary tube, while negative results appear as a thin unbroken red line of cells 
down the center along the tube wall (FIG.1A); no further grading of degree and or timing of 
agglutination was attempted. 
Strip Test– The principle of this new immunochromatographic stripw DAT method, is similar to 
the DEA 1.1 strips used for blood typing and was performed according to manufacturer’s instructions. 
19 Briefly, 5 drops of diluent (approximately 225 µl) included in testing kit were placed into one 
microtiter plate well or a 3 ml glass tube.  Washed RBCs (10 µl) were added and mixed for 10 
seconds.  The tip of the strip was then placed into RBC suspension for 6 min, allowing RBCs to 
diffuse to the top. The strip is impregnated at 2 levels forming band patterns: a control lectin labeled 
“C” that binds to all canine RBCs and about 1 cm below is the antiglobulin testing (labeled “AT”) site 
with reagent M. After incubation, the strip was removed and its banding pattern immediately read.  A 
red band at “C” had to be evident for the test to be valid.  Any band intensity at “AT” was considered 
DAT+, indicating the presence of antibodies on the RBC surface.  Band strength ranged from 0 
(negative), 1+ (positive) to 4+ (strongly positive), based on subjective visual examination (FIG.1B). 
Erythrocytic OF Technique– The OFT was performed by adding 15 µl non-lipemic EDTA 
blood (PCV was adjusted to ~25% by adding PBS or removing plasma) to 2.5 ml of 13 different 
hypotonic sodium chloride concentrations ranging from 8.5% (physiological saline concentration) to 
0% (distilled water), to measure the fragility of RBCs. For every anemic patient assessed, control 
blood was tested simultaneously. Suspensions were incubated for 45 min at room temperature and 
then centrifuged for 10 min at 2000 g. The supernatant (300 µL) was pipetted in a 96-flat bottomed 
well plate and assessed by a spectrophotometerx measuring the optical density at 550 nm: the degree 
of hemolysis at each saline concentration was expressed as percent of the value of complete lysis 
(sample in distilled water) compared to erythrocytes in 0.85% sodium chloride solution without 
incubation and OF curves were plotted12, 34, 41. Particular attention was given to the specific saline 
concentrations at which 5% (OF 5%), 50% (OF 50%) and 90% (OF 90%) of  erythrocytes were lyzed. 
One dog was not assessed by OFT because of lipemia. 
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Results 
 
Assessment of various DAT techniques 
In order to assess the various Coombs’ test techniques, (1) RBCs from DEA 1.1+ and DEA 1.1- 
dogs were incubated with polyclonal anti-DEA 1.1 alloantibodies and then DATs were performed. 
Using the techniques described in the method section, samples from 18 non-anemic DEA 1.1+ dogs 
gave consistently strongly positive results with the Microtiter, Strip, Gel as well as Capillary; using 
both reagents M and V. A sample was considered to be DAT+ when the Microtiter was ≥8 and ≥4 
with reagent M and V, respectively, or showed 2+ agglutination by Gel, any band at “AT” with the 
Strip or any beads with the Capillary. In contrast, 15 samples from DEA 1.1- dogs were uniformly 
negative with all DAT methods applied. Similarly, (2) when using anti-DEA 4 alloantibodies strongly 
positive results with 4 DEA 4+ dogs were observed, but no DEA 4- samples were available for this 
study. Finally, (3) RBCs and plasma from 4 known DAT+ dogs with IMHA (initially assessed at 
VHUP), gave consistently positive results by all methods and both reagents used in this study; while 
samples from 18 healthy dogs were DAT-. 
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Tables 
Table 1 
 
Hematology results of 105 anemic and non-anemic dogs with negative or positive DAT results. 
(based upon Microtiter M method) 
 
Anemia Non-anemic Anemic 
DAT result DAT- DAT- DAT+ 
Dogs tested, n 59 26 20 
PCV (%), mean ±SD 51.1±4.1 24.4±6.4 17.5±5.6 
              median (range) 53 (40-56) 25 (11-36) 16 (9-31) 
Plasma Hb  in g/dl, mean±SD 0.2±0.3 0.3±0.2 0.5±0.8 
                             median (range) 0.0 (0-1.3) 0.2 (0.1-0.5) 0.3 (0-3.3) 
Spherocytosis, n (%) 0 0 15 (75) 
Autogglutination pre-washing, n/n tested (%) 0/59 (0) 4/26 (15) 16/20 (80) 
Increased osmotic fragility, n/n tested (%) 0/28 (0) 4/12 (33) 15/15 (100) 
 
n, number of dogs; SD, standard deviation; Hb, hemoglobin 
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Table 2 
 
Agreement of DAT results between Microtiter, Gel, Strip and Capillary method as well as 
spherocytosis, agglutination and osmotic fragility test results, using the Microtiter M method as 
reference and interrater agreement with Cohen’s Kappa value. 
 
Technique Result 
Dogs 
(n) 
True  
+       - 
False  
+       - 
Sensitivit
y (%) 
Specificit
y (%) 
Concordance 
(%) 
k SE 95% CI 
DAT+ (strength)              
    Microtiter M  ≥8 105 20 85 0 0 100.0 100.0 100.0 1 0 1 
    Microtiter V ≥4 105 19 85 0 1 95.0 100.0 99.0 0.97 0.03 0.91 - 1 
    Gel >2+ 99 19 79 0 1 95.0 100.0 99.0 0.97 0.03 0.91 - 1 
    Strip ≥1+ 105 19 84 1 1 95.0 98.8 98.1 0.94 0.04 0.85 - 1 
    Capillary + 78 16 61 1 0 100.0 98.4 98.7 0.96 0.04 0.89 - 1 
Spherocytosis >3/10 105 15 85 0 5 75.0 100.0 95.2 0.83 0.07 0.68-0.98 
Agglutination + 105 16 81 4 4 80.0 95.3 92.4 0.75 0.08 0.59-0.92 
Osmotic Fragility Fragile 55 15 36 4 0 100.0 90.0 92.7 0.83 0.08 0.67-0.99 
 
n, Total number of samples tested for each method; +, Positive; -, Negative; k, 
Cohen’s Kappa Value; SE, Standard Error; CI, Confidence Interval 
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Table 3  
 
Laboratory results of one DAT+ dog with IMHA monitored for 126 days. 
 
Days post treatment 0 7 74 97 126 
PCV 17 32 33 38 43 
Spherocytes yes yes yes no no 
Autoagglutination no no no no no 
DAT + + + - - 
   Microtiter M titer 512 256 256 0 0 
   Microtiter V titer 128 64 32 0 0 
   Gel grade 4+ 4+ 3+ 0 0 
   Strip grade 3+ 2+ 1+ 0 0 
   Capillary + + + 0 0 
Increased Osmotic Fragility yes yes yes no no 
 
+, positive; -, negative 
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Table 4 
 
Osmotic fragility test results: Grouping according to shape of osmotic fragility curves and average 
saline concentrations for defined lysis values in 55 dogs. 
 
Osmotic Fragility Curves Anemia DAT n 
Osmotic Fragility (mean±SD) 
5% 50% 90% 
Normal 
no - 28 0.50 ±0.06* 0.40 ±0.05* 0.29 ±0.10 
yes - 8 0.54 ±0.05† 0.42 ±0.04† 0.30 ±0.08† 
Right shifted yes 
yes 
- 
+ 
4 
15 
0.65 ±0.02†∆ 
0.76 ±0.07*∆ 
0.52 ±0.01† 
0.57 ±0.11* 
0.44 ±0.04†∆ 
0.30 ±0.13∆ Right shifted or flattened 
 
n, number of dogs; SD, standard deviation; OF, osmotic fragility 
*, difference between mean hemolysis at OF 5% and 50% of 28 non-anemic DAT- dogs with a normal 
OF and 15 anemic DAT+ dogs with an increased OF (p=0.002). 
†, difference between mean hemolysis at OF 5%, 50%, 90% of 8 anemic DAT- dogs with a normal 
OF and 4 anemic DAT- dogs with an increased OF (p<0.001). 
∆, difference between mean hemolysis at OF 5% (p=0.002) and 90% (p=0.034) of 4 anemic DAT- and 
15 DAT+ dogs with an increased OF. 
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Figures 
Figure 1 
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Figure 2 
 
Comparison of DAT results of Microtiter-M with Microtiter-V (A), Strip (B) and Gel (C) methods for 
105 dogs. Microtiters are expressed logarithmically; Strip and Gel grading is shown linearly.  
Each bullet (◆) represents results from both methods compared for each sample with a linear 
regression (––). The shaded area refers to the range of DAT- results. Numbers of samples tested are 
varying, depending on the applied method. 
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Figure 3 
 
Osmotic fragility test curves results curves:  
(A) DAT+ ( )and DAT- ( ) control dog. Note right shifted curve for DAT+ dog. 
(B) Note right shifted and flattened curve, same as above. 
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Footnotes 
 
                                                        
a Wright Giemsa stain (Diff Quick Fix, Medion Diagnostics, Düdingen, Switzerland) 
b DPBS (1x) : Dulbecco’s Phosphate Buffered Saline, 1000ml, Gibco by Life Technologies 
Corporation, Grand Island, NY, USA 
c  Clay Adams Sero-Fuge 2002 Series Centrifuge, BD Diagnostics, NJ, USA 
d HemoCue® AB- A Quest Diagnostics Company, Ängelholm, Sweden. 
e 96-well round bottom microtiter plate (Linbro, Flow Laboratories Inc., McLean, VA, USA) 
f MP Biomedicals website. Canine Coombs’ Reagent 5ml, MP Bio, Irvine, CA, USA. Available at: 
http://www.mpbio.com/CH/Pages/Product.aspx?pid=08646351. Accessed April 22, 2012. 
g VMRD: Veterinary Medical Research and Development website. Canine Coombs’ Reagent 5ml, 
VMRD, Inc, Pullman, WA, USA. Available at: 
http://www.vmrd.com/Pages/ProductDetail.aspx?productId=392-5&PI=0&RPP=25. Accessed April 
22, 2012. 
h Capillary : Micro-hematocrit capillary tubes- Fischer Scientific, Pittsburgh, PA, USA 
i BioRad- DiaMed website. ID-Gel canine antibody screening system and antiglobulin test, provided 
by DiaMed, Cressier-sur-Morat, Switzerland. Available at: 
http://www.diamed.ch/pdfs/B004024_50540_07.11_GEFISP.pdf. Accessed April 22, 2012. 
j Alvedia website. Blood typing quick test and immunochromatographic Antiglobulin Strip, provided 
by Alvedia, Lyon, France. Available at: http://www.alvedia.com/fr/QT. Accessed April 22, 2012. 
k Excel 2004, Microsoft Ltd, Reading, UK  
l http://vassarstats.net/kappa.html 
m IBM SPSS Statistics 21, Armonk, NY, USA. 
n Jackson KV, Withnall E, Giger U: Initial assessment of a novel gel column Coombs’ test to detect 
auto- and alloantibodies in dogs. Abstract. J Vet Intern Med 21: 623, 2007. 
o DPBS (1x) : Dulbecco’s Phosphate Buffered Saline, 1000ml, Gibco by Life Technologies 
Corporation, Grand Island, NY, USA 
p MP Biomedicals website. Canine Coombs’ Reagent 5ml, MP Bio, Irvine, CA, USA. Available at: 
http://www.mpbio.com/CH/Pages/Product.aspx?pid=08646351. Accessed April 22, 2012. 
q VMRD: Veterinary Medical Research and Development website. Canine Coombs’ Reagent 5ml, 
VMRD,  Inc, Pullman, WA, USA. Available at: 
http://www.vmrd.com/Pages/ProductDetail.aspx?productId=392-5&PI=0&RPP=25. Accessed April 
22, 2012. 
r Pipetter : Marsh Bio Product Inc.- Abgene In., Rochester, NY 
s BioRad- DiaMed website. ID-Gel canine antibody screening system and antiglobulin test, provided 
by DiaMed, Cressier-sur-Morat, Switzerland. Available at: 
http://www.diamed.ch/pdfs/B004024_50540_07.11_GEFISP.pdf. Accessed April 22, 2012. 
t ID-Centrifuge 12 SI, DiaMed, Cressier-sur-Morat, Switzerland. 
u Jackson KV, Withnall E, Giger U: Initial assessment of a novel gel column Coombs’ test to detect 
auto- and alloantibodies in dogs. Abstract. J Vet Intern Med 21: 623, 2007. 
v Capillary : Micro-hematocrit capillary tubes- Fischer Scientific, Pittsburgh, PA, USA 
w Alvedia website. Blood typing quick test and immunochromatographic Antiglobulin Strip, provided 
by Alvedia, Lyon, France. Available at: http://www.alvedia.com/fr/QT. Accessed April 22, 2012. 
x Spectrophotometer VersaMax Microplate Reader, Molecular Devices, CA, USA. 
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